Who Just RaisedDallas, TX · Health Care · Form D filed Oct 1, 2026
Solaris Endovascular Inc. raised $5M
Solaris Endovascular Inc. is a biotechnology company based in Dallas, Texas. In a Form D filed with the SEC on October 1, 2026, it reported raising $4,972,500 from 45 investors as part of an offering of up to $10,000,000. The first sale in the offering took place on September 5, 2025.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Still raising. $5M of the $10M offering was still unsold at filing.
$5M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 1, 2026 | $5M | $10M | 45 |
Lead score
50 out of 100
filed recently first raise ever still raising budget to spend website found young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- solarisendovascular.com
- Amount raised
- $4,972,500
- Offering size
- $10,000,000
- Investors so far
- 45
- Minimum investment
- $2,500
- First sale
- September 5, 2025
- Securities offered
- Equity, Debt, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Dallas, Texas
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $4,972,500 | $10,000,000 | 45 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 28, 2026 · Health Care funding in Texas
Similar raises
Zippy, Inc.
Dallas, TX · filed Oct 155th Form D since 2021
Cosmetic Physician Partners, LLC
Dallas, TX · filed Oct 14
Cosmetic Physician Partners is the solution for Medical spas, Medical Aesthetics Clinics, plastic surgery clinics and cosmetic dermatology clinics.
11th Form D since 2021
Rakiya Systems, Inc.
Dallas, TX · filed Oct 9First Form DStill raising
OncoNano Medicine, Inc.
Dallas, TX · filed Oct 84th Form D since 2018Still raising
FibroBiologics, Inc.
Houston, TX · filed Oct 13
Fibrobiologics is treating and curing common chronic diseases with next generation fibroblast cell-based therapies.
6th Form D since 2025
Lucier Pharmaceuticals Inc.
Bryan, TX · filed Oct 13First Form D
Surgical Caregivers of Fort Worth, LLC
Fort Worth, TX · filed Oct 911th Form D since 2012
TMF1 Akido, LLC
Houston, TX · filed Oct 93rd Form D since 2020